• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS; TORIC IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS; TORIC IOLS Back to Search Results
Model Number ZCT225
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); No Code Available (3191)
Date of Event 03/28/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
It was reported that tecnis toric intraocular lens (model zct225, +24.0 diopter) was explanted from patient¿s right eye in secondary procedure because of patient experiencing moderate blurry vision, unexpected post op refraction and pseudophakia.Reportedly model zct150, +25.5 diopter was used as replacement lens for the patient.Patient was recovering from the exchange.There was no incision enlargement.No further information provided.
 
Additional Manufacturer Narrative
Device available for evaluation: yes.Returned to manufacturer on: (b)(6) 2018.Device returned to manufacturer: yes device evaluation: the product was returned to the manufacturing site for evaluation.The product was inspected by a qualified final inspection operator using 12x magnification.It can be seen that the lens was damaged on both sides.The investigation does not suggest that the damage was produced during manufacturing.Manufacturing records review: the manufacturing records for the intraocular lens were reviewed.The product was manufactured and released according to specification.A search on complaints revealed that no similar complaints were received for this production order number.Labeling review: the directions for use (dfu) was reviewed.The dfu adequately provides instructions and precautions along with warnings for the proper use and handling of the device.As a result of the investigation there is no indication of a product quality deficiency and the reported issue could not be verified.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TECNIS
Common Device Name
TORIC IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
santa ana CA
MDR Report Key7509319
Report Number9614546-2018-00461
Device Sequence Number19256619
Product Code HQL
UDI-Device Identifier05050474552814
UDI-Public(01)05050474552814(17)190713
Combination Product (Y/N)Y
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
P980040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2018
Reporter Type Manufacturer
Report Source distributor,health profession
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/24/2018
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date07/13/2019
Device Model NumberZCT225
Device Catalogue NumberZCT225U240
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/08/2018
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 04/13/2018
Supplement Date Received by Manufacturer08/07/2018
Initial Report FDA Received Date05/11/2018
Supplement Report FDA Received Date08/24/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
Date Report Sent to FDA01/01/2005
-
-